​A new study found that the rate of fatty liver diseases has increased over the past three decades. The study presented at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill has highlighted the burden of fatty liver in the US. It talks about the risk of MAFLD or metabolic-associated fatty liver disease which is also known as non-alcoholic fatty liver disease or NAFLD.​